Approved consultant to consultation pathways

North Tees and Hartlepool NHS Foundation Trust N2R Pathways

N2R/C2C Pathways agreed to date:

Gastroenterology

Obstructive Jaundice/Cholangitis Gastro1

Paediatrics

  • Botulinum toxin multidisciplinary assessment clinics for the management of spasticity in children with non-progressive brain disorders (N2R pathway) N2R Pathway
  • Therapy Pathway – Botulinum Toxin (BoNT) for Lower Limb Spasticity (Multidisciplinary Clinic) – One Cycle of BoNT treatment for Lower Limbs Lower limb
  • Therapy Pathway – Botulinum Toxin (BoNT) for Upper Limb Spasticity (Multidisciplinary Clinic) – One Cycle of BoNT treatment for Upper Limbs Upper limb

Gynaecology

Fertility pathway Gyne1

Haematology

  • Haematological cancerIron deficiency not responding to oral therapySignificant haematological abnormality found at surgical pre-assessment delaying operation Hae1
  • Generic Pathway for patients with suspected Acute Myeloid Leukaemia (AML) & Acute Lymphocytic Leukaemia (ALL)Generic Pathway for patients with suspected Chronic Lymphocytic Leukaemia (CLL)Generic Pathway for patients with suspected Chronic Myeloid Leukaemia (CML)Generic Pathway for patients with suspected Lymphoma1
  • 2
  • 3

Urology

Spinal

Spinal (N2R) pathwaySurgical follow up/complications following surgery.Merging of several pathways and the need for multiple procedures

  • Therapeutic foraminal block
  • Diagnostic nerve root block
  • Therapeutic facet joint injection
  • Diagnostic facet joint injection
  • Therapeutic sacro-illiac injection
  • Diagnostic sacro-illiac injection
  • Therapeutic sacral epidural
  • Surgery with instrumentation
  • Surgery without instrumentation
  • Surgery with interspinous stabilisation
  • Vertebroplasty
  • Spinal
  • Worksheet2

Surgery

Colorectal cancer pathway/Crohns & Colitus Consultant to Consultant Pathway
Plus supporting information provided as follows:
The colorectal pathway developed is specifically for colorectal cancer patients and has not taken account for other conditions.IBD pathway has been updated for clarity as it may have led to a slight confusion. In the stage previously described as ‘other symptoms’ this was in reference to other symptoms of cancer. Therefore the ‘other symptoms’ is not in reference to IBS etc. These patients would be sent to GP for onwards referral as you have mentioned. This should now have been changed to prevent confusion. Therefore patients who have negative findings on colonoscopy but may have other positive symptoms of cancer may be referred onto an OPA appointment for further consultation. And then onwards onto MDT if necessary as outlined in pathway